Simulation of torsemide PKs and PDs according to different CYP2C9 phenotypes in healthy adult populations confirmed that the effect of CYP2C9 genetic polymorphisms on torsemide PK and PD diversities was not as great as the difference between disease groups. This evidence concerns the gene CYP2C9 and tetrasomy 12p.